Tuesday - November 11, 2025

Marina Bay City Opens Doors to Select Developers to Accelerate Lombok’s Landmark Multi-Billion Dollar Project

LOMBOK, INDONESIA – The multi-billion-dollar Marina Bay City in South Lombok, one of Indonesia’s most ambitious master-planned developments, is entering a new growth phase under the stewardship of LUX Property, led by Australian National Review founder and political commentator Jamie McIntyre. … Continue reading

Neuroblastoma Market Forecast (2025-2034) – Competitive Landscape, Clinical Trials, Market Size, Medication, Prevalence, Companies by DelveInsight

Neuroblastoma Market Neuroblastoma companies in the treatment market include United Therapeutics, EUSA Pharma, Y-mAbs Therapeutics, Clarity Pharmaceuticals, and many others. Neuroblastoma Market is expected to grow exponentially driven by Rising incidence of pediatric cancer, Advancements in diagnostic techniques, Strong R&D … Continue reading

Multiple Sclerosis Market Forecast 2034: Competitive Landscape, FDA Approvals, Therapies, Emerging Drugs Highlighting Zenas Biopharma’s Obexelimab Phase 2 Success and Market Insights

Multiple Sclerosis Market Key multiple sclerosis companies such as Sanofi, Immunic, InnoCare Pharma, Tiziana Life Sciences, Biogen, J-Pharma, Bristol-Myers Squibb, Polpharma Biologics, Repertoire Immune Medicines, Nervgen, Nucleome Therapeutics, Medsenic, TeraImmun, Autobahn Therapeutics, Guangzhou Lupeng Pharmaceutical, GlaxoSmithKline, ImCyse, Novartis, Biocad, Apimeds, … Continue reading

B-Cell Chronic Lymphocytic Leukemia Market Analysis 2034 – Competitive Landscape, Clinical Trials, Market Share, Therapies, Prevalence, and Key Players by DelveInsight

B-Cell Chronic Lymphocytic Leukemia Market Key B-Cell Chronic Lymphocytic Leukemia Companies are AstraZeneca, Bristol-Myers Squibb, Merck, Ascentage Pharma, BeOne Medicines, Nurix Therapeutics, and others. The B-Cell Chronic Lymphocytic Leukemia (B-CLL) market is primarily fueled by advancements in diagnostic technologies, which … Continue reading